Experimental infection of macaques with human metapneumovirus induces transient protective immunity

Journal of General Virology

Volumn 88, Issue 4, 2007, Pages 1251-1259

  van den Hoogen, Bernadette G ^a   Herfst, Sander ^a   de Graaf, Miranda ^a   Sprong, Leo ^a   van Lavieren, Rob ^a   van Amerongen, Geert ^a   Yüksel, Selma ^a   Fouchier, Ron A M ^a   Osterhaus, Albert D M E ^a   de Swart, Rik L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; HUMAN; HUMAN CELL; INOCULATION; MACACA; METAPNEUMOVIRUS; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEROCONVERSION; VIRUS INDUCTION; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, VIRAL; MACACA FASCICULARIS; METAPNEUMOVIRUS; NEUTRALIZATION TESTS; NOSE; PARAMYXOVIRIDAE INFECTIONS; PHARYNX; VIRUS SHEDDING;

ANIMALIA; HUMAN METAPNEUMOVIRUS; MACACA; PARAMYXOVIRIDAE;

EID: 34047124241     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82663-0     Document Type: Article

References (31)

1. Biacchesi, S., Skiadopoulos, M. H., Tran, K. C., Murphy, B. R., Collins, P. L. & Buchholz, U. J. (2004a). Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes. Virology 321, 247-259.
2. Biacchesi, S., Skiadopoulos, M. H., Yang, L., Lamirande, E. W., Tran, K. C., Murphy, B. R., Collins, P. L. & Buchholz, U. J. (2004b). Recombinant human Metapneumovirus lacking the small hydrophobic SH and /or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J Virol 78, 12877-12887.
3. Biacchesi, S., Pham, O. N., Skiadopoulos, M. H., Murphy, B. R., Collins, P. L. & Buchholz, U. J. (2005). Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates. J Virol 79, 12608-12613.
4. Buchholz, U. J., Biacchesi, S., Pham, O. N., Tran, K. C., Yang, L., Luongo, C. L., Skiadopoulos, M. H., Murphy, B. R. & Collins, P. L. (2005). Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity. J Virol 79, 6588-6597.
5. Chanock, R. M., Murphy, B. R. & Collins, P. L. (2001). Parainfluenza viruses. In Fields Virology, 4th edn, vol. 1, pp. 1341-1379. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
6. Collins, P. L., Chanock, R. M. & Murphy, B. R. (1996). Respiratory syncytial virus. In Fields Virology, 4th edn, vol. 1, pp. 1443-1485. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
7. De Swart, R. L., Kuiken, T., Timmerman, H. H., van Amerongen, G., van den Hoogen, B. G., Vos, H. W., Neijens, H. J., Andeweg, A. J. & Osterhaus, A. D. M. E. (2002). Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection. J Virol 76, 11561-11569.
8. Durbin, J. E. & Durbin, R. K. (2004). Respiratory syncytial virus-induced immunoprotection and immunopathology. Viral Immunol 17, 370-380.
9. Ebihara, T., Endo, R., Ishiguro, N., Nakayama, T., Sawada, H. & Kikuta, H. (2004a). Early reinfection with human metapneumovirus in an infant. J Clin Microbiol 42, 5944-5946.
10. Ebihara, T., Endo, R., Kikuta, H., Ishiguro, N., Ishiko, H., Hara, M., Takahashi, Y. & Kobayashi, K. (2004b). Human metapneumovirus infection in Japanese children. J Clin Microbiol 42, 126-132.
11. Griffin, D. E. (2001). Measles virus. In Fields Virology, 4th edn, vol. 1, pp. 1401-1441. Edited by D. M. Knipe & P. M. Howley, Philadelphia, PA: Lippincott Williams & Wilkins.
12. Hall, C. B., Walsh, E. E., Long, C. E. & Schnabel, K. C. (1991). Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 163, 693-698.
13. Henderson, F. W., Collier, A. M., Clyde, W. A. & Denny, F. W. (1979). Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med 300, 530-534.
14. Herfst, S., de Graaf, M., Schickli, J. H., Tang, R. S., Kaur, J., Yang, C. F., Spaete, R. R., Haller, A. A. & other authors (2004). Recovery of human metapneumovirus genetic lineages A and B from cloned cDNA. J Virol 78, 8264-8270.
15. Kakuk, T. J., Solke, K., Brideau, R. J., Zaya, R. M., Cole, S. L., Zhang, J. Y., Roberts, E. D., Wells, P. A. & Wathen, M. W. (1993). A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine. J Infect Dis 167, 553-561.
16. Kuiken, T., van den Hoogen, B. G., van Riel, D. A., Laman, J. D., van Amerongen, G., Sprong, L., Fouchier, R. A. & Osterhaus, A. D. (2004). Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract. Am J Pathol 164, 1893-1900.
17. Leung, J., Esper, F., Weibel, C. & Kahn, J. S. (2005). Seroepidemiology of human metapneumovirus (hMPV) on the basis of a novel enzyme-linked immunosorbent assay utilizing hMPV fusion protein expressed in recombinant vesicular stomatitis virus. J Clin Microbiol 43, 1213-1219.
18. MacPhail, M., Schickli, J. H., Tang, R. S., Kaur, J., Robinson, C., Fouchier, R. A. M., Osterhaus, A. D. M. E., Spaete, R. R. & Haller, A. A. (2004). Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design. J Gen Virol 85, 1655-1663.
19. Maertzdorf, J., Wang, C. K., Brown, J. B., Quinto, J. D., Chu, M., de Graaf, M., van den Hoogen, B. G., Spaete, R. & other authors (2004). Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages. J Clin Microbiol 42, 981-986.
20. Morrow, B. M., Hatherill, M., Smuts, H. E., Yeats, J., Pitcher, R. & Argent A. C. (2006). Clinical course of hospitalised children infected with human metapneumovirus and respiratory syncytial virus. J Paediatr Child Health 42, 174-178.
21. O'Doherty, U., Swiggard, W. J. & Malim, M. H. (2000). Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 74, 10074-10080.
22. Reed, L. J. & Muench, H. (1938). A simple method of estimating fifty percent end points. Am J Hyg 27, 493-497.
23. Skiadopoulos, M. H., Biacchesi, S., Buchholz, U. J., Riggs, J. M., Surman, S. R., Amaro-Carambot, E., McAuliffe, J. M., Elkins, W. R. & other authors (2004). The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic: relatedness. J Virol 78, 6927-6937.
24. Tang, R. S., MacPhail, M., Schickli, J. H., Kaur, J., Robinson, C. L., Lawlor, H. A., Guzzetta, J. M., Spaete, R. R. & Haller, A. A. (2004). Parainfluenza virus type 3 expressing the native or soluble fusion (F) protein of respiratory syncytial virus (RSV) confers protection from RSV infection in African green monkeys. J Virol 78, 11198-11207.
25. Tang, R. S., Mahmood, K., MacPhail, M., Guzzetta, J. M., Haller, A. A., Liu, H., Kaur, J., Lawlor, H. A. & other authors (2005). A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys. Vaccine 23, 1657-1667.
26. van den Hoogen, B. G., de Jong, J. C., Groen, J., Kuiken, T., de Groot R., Fouchier, R. A. & Osterhaus, A. D. (2001). A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7, 719-724.
27. van den Hoogen, B. G., van Doornum, G. J., Fockens, J. C., Cornelissen, J. J., Beyer, W. E., Groot, R. R., Osterhaus, A. D. & Fouchier, R. A. (2003). Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis 188, 1571-1577.
28. van den Hoogen, B. G., Herfst, S., Sprong, L., Cane, P. A., Forleo-Neto, E., de Swart, R. L., Osterhaus, A. D. & Fouchier, R. A. (2004). Antigenic and genetic variability of human metapneumoviruses. Emerg Infect Dis 10, 658-666.
29. Wilkesmann, A., Schildgen, O., Eis-Hubinger, A. M., Gelkowski, T., Glatzel, T., Lentz, M. J., Bode, U. & Simon, A. (2006). Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections. Eur J Pediatr 165, 467-475.
30. Williams, J. V., Martino, R., Rabella, N., Otegui, M., Parody, R., Heck, J. M. & Crowe, J. E., Jr (2005). A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J Infect Dis 192, 1061-1065.
31. Williams, J. V., Wang, C. K., Yang, C. F., Tollefson, S. J., House, F. S., Heck, J. M., Chu, M., Brown, J. B. & other authors (2006). The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J Infect Dis 193, 387-395.